KMT2A部分串联重复(KMT2A-PTD)的特征是跨越6-8个外显子的大量内部重复,见于10%的AML和MDS并且与不良结局相关,在NCCN指南中,将KMT2A-PTD纳入了MDS的IPSS-M评分。 影响MDS患者的预后因素包括两个方面:①病人/患者相关因素,包括年龄...
本发明公开了一种用于检测KMT2A‑PTD融合基因的试剂盒、其方法和应用,所述试剂盒至少包含引物对和探针,所述引物对包含第一正向引物、第二正向引物和反向引物;其中,所述第一正向引物的核苷酸序列如SEQIDNO.1所示,所述第二正向引物的核苷酸序列如SEQIDNO.2所示,所述反向引物的核苷酸序列如SEQIDNO.3所示,所述...
KMT2A-PTD (E2-E8Dup_gDNA) Reference Standard询价产品描述 产品数据库CBP10636 Format Genomic DNA Description N/A Technical Data DNA Change c.22807bp-Duplication AA Change PTD (E2-E8Dup) Mutation type Dup-Like Zygosity N/A Allelic Frequency N/A Transcript NM_005933.4 ...
一种检测髓系肿瘤KMT2A-PTD的软件是由天津协和博精医学诊断技术有限公司著作的软件著作,该软件著作登记号为:2024SR0903937,属于分类,想要查询更多关于一种检测髓系肿瘤KMT2A-PTD的软件著作的著作权信息就到天眼查官网!
》杂志在线发表题名为“The Application of Targeted RNA Sequencing for KMT2A Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia.”——靶向RNA测序在KMT2A-PTD鉴定...
专利权项:1.一种用于检测KMT2A-PTD融合基因的试剂盒,其特征在于,所述试剂盒至少包含引物对和探针,所述引物对包含第一正向引物、第二正向引物和反向引物;其中,所述第一正向引物的核苷酸序列如SEQIDNO.1所示,所述第二正向引物的核苷酸序列如SEQIDNO.2所示,所述反向引物的核苷酸序列如SEQIDNO.3所示,所述探针的核...
关于我们 百度学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们保持学习的态度,不忘初心,砥砺前行。了解更多>> 友情链接 联系我们 合作与服务 期刊合作 图书馆合作 下载产品手册意见反馈 ©2025 Baidu 百度学术声明 使用百度前必读...
KMT2AChromosome aberrationsMutationPrognosisTo define the biological differences in acute myeloid leukaemia (AML) with KMT2A gene involvements and their prognostic impact, we compared 190 de novo AML patients at diagnosis, 95 harbouring KMT2A-rearrangement (KMT2Ar) and 95 KMT2A-PTD by performing ...
had an unfavourable outcome, particularly in patients > 60 years. Patients with KMT2A r were younger compared to patients with KMT2A -PTD (mean 52 vs 65 years, p < 0.001) and had a higher rate of additional cytogenetic abnormalities (ACA) (46% vs 25% of cases). In both ...
Acutemyeloidleukemia(AML)withpartialtandemduplicationofhistone-lysineN-methyltransferase2A(KMT2A-PTD)is asubtypeofAMLandisassociatedwithadversesurvival,yetthemolecularpathogenesisofKMT2A-PTDisnotfully understood.DNAmethyltransferase3A(DNMT3A)ismutatedinvariousmyeloidneoplasmsincludingAML,especially attheArg882.Recently...